13G/A filed by Squadron Capital Management LLC
Squadron Capital Management LLC and 3 other reporting persons reported 9,718,683 CCCC shares, 7.9% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 16:58:02 UTC.
- Accession
- 0002050709-26-000030
- Filer
- CIK 2050709
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- CCCC · C4 Therapeutics, Inc.
- Shares
- 9,718,683
- Percent of class
- 7.9%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: every reporting person reports the same shares (a chain of control). The page shows the largest row.
Read for the filer group Squadron Capital Management LLC.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Squadron Master Fund LP | PN | 0 | 9,718,683 | 0 | 9,718,683 | 9,718,683 | 7.9% |
| Squadron Capital Management LLC | IA,HC | 0 | 9,718,683 | 0 | 9,718,683 | 9,718,683 | 7.9% |
| Matthew Sesterhenn | HC,IN | 0 | 9,718,683 | 0 | 9,718,683 | 9,718,683 | 7.9% |
| William Blank | HC,IN | 0 | 9,718,683 | 0 | 9,718,683 | 9,718,683 | 7.9% |